Colorectal cancer
Conditions
Interventions
None listed
Sponsors
Yokohama City University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with histologically confirmed colorectal cancer Patients scheduled for primary tumor resection Patients whose hemoglobin level at the initial visit meets the following criteria: Male: < 13.0 g/dL Female: < 12.0 g/dL
Exclusion criteria
Exclusion criteria: Patients undergoing emergency surgery with primary tumor resection Patients with severe anemia requiring blood transfusion at the initial visit Patients with contraindications to iron therapy (e.g., hepatic or renal dysfunction, myelodysplastic syndromes [MDS], hemochromatosis, thalassemia, hemolytic anemia) Patients who have already received preoperative anemia treatment (blood transfusion within 1 month or erythropoietin use within 3 months) Patients deemed unsuitable for participation in this study by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase in hemoglobin (Hb): the change in Hb level from the start of treatment to the time of surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative blood transfusion volume Incidence of perioperative complications Changes in laboratory values (ferritin, transferrin saturation [TSAT], and C-reactive protein [CRP]) | — |
Countries
Japan
Contacts
Public ContactSuguru Nukada
Yokohama City University Medical Center Department of Gastroenterological Surgery, Gastroenterological Center
Outcome results
None listed